Bacterial infections spanning from local wound infections, affecting patients with non-healing leg ulcers, postoperative wounds or burns, to severe infections and sepsis, are significant medical problems.
Today's anti-infective treatments do not address the excessive activation of inflammatory pathways during infection and sepsis, and resistance problems are increasing. Hence, there is a huge unmet need for novel therapies that go beyond mere classical antibacterial effects, and which also selectively modulate both pro- and anti-inflammatory pathways during infections.
The purpose of our research is to define and utilize new knowledge on innate immunity, with a focus on endogenous antimicrobial and immunomodulatory peptides and proteins, in order to develop the next generation's anti-infective treatments, with potential applications for skin infections and burns, postoperative profylaxis, but also for invasive infections and sepsis.